WAVE Life Sciences Ltd (WVE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

7 STRAITS VIEW SINGAPORE, SINGAPORE 018936

Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.

Data as of 2021-10-17 10:09:56 -0400
Market Cap261.445 Million Shares Outstanding50.766 Million Avg 30-day Volume363.065 Thousand
P/E Ratio-1.82677 Dividend Yield EPS-3.07
Price/Sales16.69 Debt to Equity6.95 EBITDA-139.976 Million
Price to Book Value8.8 Forward PE-1.83 Enterprise Value117.605 Million
Total Cash143.84 Million Current Debt46.721 Million Gross Profit15.665 Million
BETA1.12345 52-week High/Low12.17 / 4.48 Next Earnings Date2021-11-08 Price to Cash FLow (P/CF) -7.1371
Data provided by IEX Cloud
View SEC Filings from WVE instead.

View recent insider trading info

Funds Holding WVE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding WVE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CORRIGAN MARK

  • Director
21,000 2021-08-16 1

HENRY CHRISTIAN O

  • Director
42,000 2021-08-16 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
42,000 2021-08-16 2

RAWCLIFFE ADRIAN

  • Director
42,000 2021-08-16 1

VERDINE GREGORY L.

  • Director
42,000 2021-08-16 1

WAGNER HEIDI L

  • Director
21,000 2021-08-16 1

TAKANASHI KEN

  • Director
  • 10% Owner
42,000 2021-08-16 1

TAN AIK NA

  • Director
21,000 2021-08-16 1

MORAN KYLE CHIEF FINANCIAL OFFICER

  • Officer
105,792 2021-03-24 3

VARGEESE CHANDRA CHIEF TECHNOLOGY OFFICER

  • Officer
85,412 2021-02-01 1

FRANCIS CHRIS SEE REMARKS

  • Officer
78,462 2021-02-01 1

BOLNO PAUL PRESIDENT AND CEO

  • Officer
  • Director
410,976 2021-02-01 1

PANZARA MICHAEL A. SEE REMARKS

  • Officer
86,420 2021-02-01 1

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2020-08-18 0

POTT AMY

  • Director
0 2020-08-18 0

GAIERO DAVID G INTERIM CFO

  • Officer
0 2020-03-03 0

MIURA KOJI

  • Director
0 2019-08-15 0

BALDRY MARK CHIEF COMMERICAL OFFICER

  • Officer
39,000 2019-08-05 0

REGNANTE KEITH CHIEF FINANCIAL OFFICER

  • Officer
29,186 2019-03-07 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
  • 10% Owner
7,775,207 2019-01-24 0

TANAKA MASAHARU

KAGOSHIMA SHINSANGYO SOUSEI INVESTMENT LIMITED PARTNERSHIP

  • Director
  • 10% Owner
No longer subject to file 2017-09-15 0

GUERCIOLINI ROBERTO SEE REMARKS

  • Officer
4,000 2016-12-07 0

WADA TAKESHI

  • Director
0 2016-11-10 0

TANAKA MASAHARU

  • Director
  • 10% Owner
0 2016-11-10 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

  • Director
  • 10% Owner
4,041,591 2015-11-10 0

TAKANASHI KEN

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

  • Director
  • 10% Owner
1,697,467 2015-11-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
WAVE LIFE SCIENCES LTD WVE 2021-10-22 22:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 21:45:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 21:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 20:45:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 20:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 19:45:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 19:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 18:45:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 18:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 17:45:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 17:15:03 UTC -0.4079 0.4779 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 16:45:03 UTC -0.2074 0.2774 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 16:15:04 UTC -0.2074 0.2774 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 15:45:03 UTC -0.2074 0.2774 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 15:15:03 UTC -0.2074 0.2774 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 14:45:03 UTC -0.1913 0.2613 500000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 14:15:03 UTC -0.1913 0.2613 450000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 13:45:03 UTC -0.1913 0.2613 450000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 13:15:03 UTC -0.1913 0.2613 450000
WAVE LIFE SCIENCES LTD WVE 2021-10-22 12:45:03 UTC -0.1913 0.2613 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund WVE -146.0 shares, $-2997.38 2019-09-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio WVE -27200.0 shares, $-181152.0 2021-06-30 N-PORT

Elevate your investments